Application and Safety Evaluation of Integrated TCM-WM in the Treatment of COVID-19

  • Huaijie Wang Department of Translational Medical Center, Weifang Second People’s Hospital, Weifang Respiratory Disease Hospital
  • Lei Chen Department of Translational Medical Center, Weifang Second People’s Hospital, Weifang Respiratory Disease Hospital
  • Jinhua Dong Weifang Medical University
  • Guoru Yang Department of Translational Medical Center, Weifang Second People’s Hospital, Weifang Respiratory Disease Hospital
  • Meihua Qu Department of Translational Medical Center, Weifang Second People’s Hospital, Weifang Respiratory Disease Hospital
DOI: https://doi.org/10.18686/aem.v11i3.242
Keywords: COVID-19, TCM-WM, CT, Long Covid, Omicron

Abstract

Introduction: With the emergence of more infectious mutant strains and the appearance of new crown sequelae, early precise treatment is particularly important. The traditional Chinese medicine and Western medicine (TCM-WM) treatment plan exhibits unique superiority in the COVID-19 treatment, but the efficacy and safety have not been fully elucidated. Methods: A analysis of the clinical characteristics of 7 COVID-19 patients diagnosed in our hospital, as well as the results of precise individual intervention treatment with TCM-WM, including laboratory examination, and CT changes of imaging. Results: On admission, laboratory results showed that 7 patients' overall Lymphocyte count (LYM#), Percent Lymphocytes (LYM %), and Alanine aminotransferase (ALT) were reduced, but Neutrophil percentage (NEU%) were increased. CT imaging showed that most patients had multiple patchy shadows and ground-glass shadows in both lungs. After TCM-WM treatment, the above pathological states were significantly improved. All patients were followed up and had a good prognosis. Conclusions: Accurate therapy with TCM-WM can quickly and effectively alleviate and treat patients with COVID-19, without severe Long Covid.

References

[1] Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022; 13:1957.

[2] Zhang S, Yang Z, Chen ZL, Li ZN, Tang YP. Efficacy and safety of "three chinese patent medicines and three tcm prescriptions" for covid-19: a systematic review and network meta-analysis. Evidence-based Complementary and Alternative Medicine 2022:1-16.

[3] Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. Medical team from Xiangya Hospital to support Hubei, China. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study. Diabetes Res Clin Pract 2020; 165:108227.


[4] Jin L, Y Xu, Yuan H. Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis. Revista da Associação Médica Brasileira 2020; 66:771-777.

[5] Gautam R, Gupta A. A Comprehensive Overview of the Paradigm of Laboratory Findings in the Diagnosis of the Pandemic Coronavirus Disease 2019 (COVID-19) in India. Open Journal of Pathology 2022; 12:10.

[6] Cao Y, Wang J, Jian F, Xiao T, Xie XS. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 2021.

[7] Zhan Z, Li J, Cheng ZJ. Rapid Antigen Test Combine with Nucleic Acid Detection: A Better Strategy for COVID-19 Screening at Points of Entry. Journal of Epidemiology and Global Health 2022; 12:13-15.

[8] Shi J, Lu Y, Zhang Y, Xia, L, Ye C, Ying Lü, et al. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19). The American Journal of Chinese Medicine 2020.

[9] Choi WJ, Lee KN, Kang EJ, Lee H. Middle East Respiratory Syndrome-Coronavirus Infection: A Case Report of Serial Computed Tomographic Findings in a Young Male Patient. Korean J Radiol 2016; 17:166-70.

[10] Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect 2020; 80:607-613.

[11] Lai H, Zhang H. Retrospective Review of Traditional Chinese Medicine Treatment of COVID-19 in China: Clinical Practice and Researches 2021.

[12] Park JG, Oladunni FS, Chiem K, Ye C, Martinez-Sobrido L. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2. Journal of Virological Methods 2021; 287:113995.

[13] National Health Commission of the People,s Republic of China. the COVID-19 Diagnosis and Treatment Program (Trial Ninth Edition) 2022.
Published
2022-11-03
Issue
Vol 11 No 3 (2022)
Section
Original Research Article

Copyright (c) 2022 Huaijie Wang

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.